The WACC of Sprint Bioscience AB (SPRINT.ST) is 6.8%.
| Range | Selected | |
| Cost of equity | 4.50% - 11.70% | 8.10% |
| Tax rate | 20.60% - 20.90% | 20.75% |
| Cost of debt | 7.00% - 7.00% | 7.00% |
| WACC | 5.0% - 8.6% | 6.8% |
| Category | Low | High |
| Long-term bond rate | 2.5% | 3.0% |
| Equity market risk premium | 5.1% | 6.1% |
| Adjusted beta | -0.59 | 0.52 |
| Additional risk adjustments | 5.0% | 5.5% |
| Cost of equity | 4.50% | 11.70% |
| Tax rate | 20.60% | 20.90% |
| Debt/Equity ratio | 1 | 1 |
| Cost of debt | 7.00% | 7.00% |
| After-tax WACC | 5.0% | 8.6% |
| Selected WACC | 6.8% | |